FORUS RAISES $150M, HITS $3B VALUATION

Forus uses artificial intelligence to accelerate the prescription process for patients, handling complex tasks like insurance verification and prior authorization that typically slow down medication access. The funding round comes months after the company's previous financing cycle, signaling investor confidence in the healthcare automation sector. The $3 billion valuation places Forus among a growing cohort of healthcare tech startups addressing administrative bottlenecks in drug distribution. The healthcare industry loses billions annually to administrative friction. Forus targets this inefficiency by automating steps that currently require manual coordination between patients, providers, and insurers. The startup operates in a competitive landscape where multiple companies are building AI solutions for healthcare workflows. Forus's focus on the prescription pathway differentiates it from broader healthcare automation platforms.